4Filing Date: Oct 5, 2026

P&G (PG) 4: Gama Paul bought 12,517 shares at $0.00 on 2026-10-01; Gama… (Oct 5, 2026)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0000080424-26-000195
Total Value$0
Trades2
Insiders1

Transaction Details

Gama Paul
CEO- Health Care·Direct
Grant · Acquire
Common Stock
Shares+12.52K
Price$0.00
Total Value$0
Shares Owned After53.35K
Transaction DateOct 1, 2026
Footnotes ▸

Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan.

Gama Paul
CEO- Health Care·Indirect · By Retirement Plan Trustee
Common Stock
Shares0
Price-
Total Value$0
Shares Owned After1.17K

Post-Transaction Holdings

Gama Paul · CEO- Health Care
SecuritySharesChange
Common Stock54.52K+12.52K (29.80%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-10-01 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: PROCTER & GAMBLE Co (PG) CIK: 0000080424 --- Reporting Owner --- Name: Gama Paul CIK: 0002110932 Role: Officer (CEO- Health Care) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-10-01 | Code: A (Grant or award) Shares: +12,517 | Price: $0.00 Shares Owned After: 53,348.8803 | Ownership: D (Direct) Footnotes: [F1] Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. --- Holdings --- [Holding #1] Security: Common Stock Ownership: I (Indirect) --- Footnotes (Complete Index) --- F1: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. --- Signature --- /s/ /s/ Jennifer DollardSmith, attorney-in-fact for Paul Gama (2026-10-05)

keid analysis is for reference only and does not constitute investment advice.